Short Wave How Gene Therapy Helped Conner Run
Aug 5, 2020
Jon Hamilton, NPR science correspondent, shares the inspirational journey of Connor Curran, a 9-year-old boy battling Duchenne muscular dystrophy. The discussion highlights groundbreaking gene therapy that has enabled Connor to run again, offering hope for thousands of children. Hamilton dives into the use of adeno-associated viruses to replace faulty genes and the challenges scientists overcame on this path. The emotional transition from animal trials to human therapy exemplifies the dedication behind this transformative medical breakthrough.
AI Snips
Chapters
Transcript
Episode notes
Connor's Early Struggles
- Connor Curran, diagnosed with Duchenne muscular dystrophy at four, struggled with mobility by first grade.
- Doctors advised his parents to focus on making him comfortable, as few treatment options existed.
AAV: A Key Tool
- Jude Samulski helped clone the AAV virus, which is harmless to humans, in 1984.
- This virus became a crucial tool in gene therapy for delivering genetic material into cells.
Duchenne's Root Cause
- Duchenne muscular dystrophy is caused by the lack of a functional DMD gene.
- This gene produces dystrophin, a protein essential for muscle health.